Allianz Asset Management
OPRX icon

Allianz Asset Management’s OptimizeRx OPRX Stock Holding History

Allianz Asset Management’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14,672
Closed -$133K – 2494
2020
Q1 		$133K Sell
14,672
-1,184
-7% -$11.2K ﹤0.01% 2373
2019
Q4 		$163K Sell
15,856
-5,551
-26% -$62.9K ﹤0.01% 2688
2019
Q3 		$310K Sell
21,407
-29,223
-58% -$452K ﹤0.01% 2517
2019
Q2 		$820K Buy
50,630
+13,111
+35% +$177K ﹤0.01% 2205
2019
Q1 		$477K Buy
+37,519
New +$488K ﹤0.01% 2337

Other funds holding OPRX

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management's OPRX Position: Q2 2020 in Review

Allianz Asset Management sold out of OptimizeRx (OPRX) in Q2 2020, closing a stake of 14,672 shares — an estimated $133K sold.

Allianz Asset Management first reported a position in OPRX in Q1 2019 and held it in 5 quarters. The position peaked at $820K in Q2 2019. 53 funds tracked by Wall St. Rank hold OPRX as of Q2 2020.

  • Allianz Asset Management reported no remaining OptimizeRx position as of Q2 2020 after selling out during the quarter.
  • Allianz Asset Management sold 14,672 OptimizeRx shares in Q2 2020, an estimated $133K.
  • Allianz Asset Management first reported a position in OptimizeRx in Q1 2019 and held it in 5 quarters.
  • Allianz Asset Management's OptimizeRx position peaked at $820K in Q2 2019.
  • 53 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2020.

Based on Allianz Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.